Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05210699 · ClinicalTrials.gov registry record · NA
CSD201201: Study to Assess Elements of Abuse Liability for Electronic Nicotine Delivery System P12
A NA study, sponsored by RAI Services Company.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT05210699 is a NA study that has completed, run by RAI Services Company. The registered enrollment target is 36 participants.
The verdict
NCT05210699, a NA study, has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a randomized, open-label, 6-way crossover, multi-site study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics \[PD\]), and nicotine uptake (pharmacokinetics \[PK\]) during and following ad libitum use of the Electronic Nicotine Delivery Systems (ENDS) investigational products (IPs) in generally healthy combustible cigarette (CC) smokers and dual users of CC and ENDS.
Interventions
- OTHER Product A
- OTHER Product B
- OTHER Product C
- OTHER Product D
- OTHER Product E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-03-21 |
| Est. Completion | 2022-05-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05210699
The ClinicalTrials.gov registry entry for NCT05210699 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Product A is the first listed.
NCT05210699 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05210699 about?
NCT05210699 is a clinical study titled "CSD201201: Study to Assess Elements of Abuse Liability for Electronic Nicotine Delivery System P12". This is a randomized, open-label, 6-way crossover, multi-site study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics \[PD\]), and nicotine uptake (pharmacokinetics \[PK\]) during and following ad libitum use of the Electr...
What is the current status of trial NCT05210699?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2022-03-21. Estimated completion is 2022-05-17.
What interventions are being tested in trial NCT05210699?
The interventions under investigation include: Product A (OTHER), Product B (OTHER), Product C (OTHER), Product D (OTHER), Product E (OTHER).
Who is sponsoring clinical trial NCT05210699?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.